Brief: Astrazeneca Pharma India Gets Show Cause Notice From National Pharmaceutical Pricing Authority
12/09/2025 11:43
Sept 12 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: ASTRAZENECA PHARMA INDIA - GETS SHOW CAUSE NOTICE FROM NATIONAL PHARMACEUTICAL PRICING AUTHORITY ASTRAZENECA PHARMA INDIA LTD - NPPA ALLEGES OVERCHARGING FOR 'SYMBICORT TURBUHALER' ASTRAZENECA PHARMA INDIA LTD - CLAIM QUANTUM 605 MILLION RUPEES Source text: ID:nNSEb5xzyw Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan